Healthy Longevity Starts in Everyday Life: What the Pharmaceutical Industry Should Know About Long-Term Patient Support

7. Oct 2026 | B2B_Patient_Engagement

When people talk about longevity, the focus is often on new active substances, biomarkers, prevention programs or technological innovations. For many people, however, a long life in good health depends on a less spectacular factor: their daily management of health routines, chronic conditions and medication.

Healthy longevity, on the other hand, is not merely about extending lifespan. The focus is on how long people can maintain their functional abilities, independence and quality of life. The World Health Organisation accordingly describes healthy ageing as a process in which the functional abilities that enable well-being in later life are developed and maintained.

This broadens the perspective for pharmaceutical companies. Alongside the development of effective therapies, it is becoming increasingly important to consider how treatments can be integrated as naturally as possible into patients’ everyday lives over many years, without placing an unnecessary burden on them. To better understand this perspective, we need further insights into patients’ everyday health and treatment routines.

 

Healthy Longevity Is More Than Just Anti-Ageing

In the general public’s perception, longevity is often associated with anti-ageing products, dietary supplements or experimental interventions. At the same time, the biology of ageing is an established field of research that investigates the cellular and molecular mechanisms of ageing processes and seeks ways to influence them. Healthy Longevity broadens this perspective to include the question of how people can live as long as possible in good health and with autonomy throughout their lives.

Healthy Longevity encompasses, amongst other things:

  • the prevention of avoidable diseases,

  • the early detection of health risks,

  • the long-term management of chronic conditions,

  • the maintenance of physical and cognitive functions,

  • the promotion of independence and quality of life,

  • and care that adapts to changing needs throughout the life course.

This means that healthy longevity is not just a matter for geriatric medicine. Many of the factors that influence health in later life develop over a period of decades.

Cardiometabolic diseases, chronic respiratory diseases, autoimmune diseases and mental health issues often begin long before retirement age. Their long-term consequences depend also on how early they are detected, how consistently they are treated and how well patients are supported in their everyday lives.

Healthy Longevity is therefore not shaped solely by prevention and medical innovations. If medical conditions are already present, effective long-term treatment and good disease management can help to limit their consequences and maintain quality of life.

 

Healthy Longevity Is Shaped by Everyday Life

Patients spend only a small proportion of their time in doctors’ offices, pharmacies or hospitals. However, health is shaped primarily in everyday life. This applies to health-promoting routines and managing risk factors, as well as to disease and medication management for existing conditions.

This raises practical questions:

  • How can health-promoting routines be integrated into daily life over the long term?

  • How can changes in health be recognized and assessed early on?

  • How can treatment be balanced with work, family, or travel?

  • How can patients successfully manage multiple medications or increasingly complex treatments?

  • How do information and support needs change with age, life circumstances, and health status?

These situations cannot be fully addressed by a single prescription or a one-time visit to the doctor. They highlight why long-term care consists not only of informed medical decisions, but also of guidance, health literacy, and recurring routines.

For pharmaceutical companies, this raises the question of how therapies and accompanying services can remain relevant and practical for everyday life over extended periods of time. Long-term care therefore also means paying closer attention to patients’ daily lives.

 

Patient Activation Is Not the Same as Adherence

In the context of Healthy Longevity, Patient Activation is relevant because people make numerous health-related decisions on their own—consciously or unconsciously—over many years. Patient activation is based on the premise that people have the knowledge, skills, and confidence to actively shape their own health and care.

This may include noticing changes in one’s health, interpreting information, asking questions, developing health-promoting routines, and participating in treatment decisions. Adherence can also be linked to patient activation: Those who are well-informed and able to contribute competently to their own care have key prerequisites for understanding treatment decisions and implementing them in daily life. Whether a treatment is followed as prescribed also depends on many factors, such as:

  • the perceived necessity of the treatment,

  • possible side effects,

  • the complexity of the medication regimen,

  • personal beliefs and experiences,

  • financial or organizational burdens,

  • health literacy and the clarity of the information provided,

  • the relationship with the healthcare professionals providing treatment.

A patient-centered strategy should therefore not be aimed solely at demanding a specific behavior. The first step is to understand what obstacles exist and what form of support is appropriate in a given situation.

Such needs change, especially with long-term treatments. A person who has just received a diagnosis may need different information than someone who has been living with the same condition for ten years.

 

Long-Term Care Requires Continuous Touchpoints

Traditional care is often organised around specific events: diagnosis, prescription, follow-up, and therapy adjustment. However, there are often weeks or months in between during which patients largely manage their treatment independently. These gaps also represent untapped potential for Healthy Longevity approaches.

This is where ongoing digital services can create additional touchpoints. They do not replace medical care, but complement it with information and organisational support in everyday life.

The medication app mediteo is one example, supporting users in organising their medication, keeping track of when to take it, and documenting health-related information. It also provides educational content on the routine use of treatments as well as on diseases and physiology. What matters here is not just a single feature, but rather the continuous presence in users’ day-to-day medication management.

At the same time, continuous digital touchpoints combined with data analytics can help provide a better understanding of healthcare from the patient’s perspective. For example, it is relevant to understand at which stages of a treatment patients have a particular need for information or support, what challenges arise with complex medication plans, and how needs vary over the course of a disease. Another question is which information is actually understood and perceived as helpful. Which data sources are suitable for investigating such questions depends largely on the specific research question.

 

Patients’ Needs Are Not Static

It is not just the individual touchpoints that change over time, patients’ needs also evolve. Particularly in the case of chronic conditions, patient journeys are rarely linear: life circumstances change, further conditions may develop, and medication plans can become more complex. At the same time, motivation, health literacy and digital skills may fluctuate.

Patient Journeys should therefore not be viewed solely up to the start of treatment or the first follow-up appointment. As the journey progresses, new needs for information and support may arise, for example in the event of changes to treatment, increasing multimorbidity or changes in life circumstances. Family members or other carers may also take on a greater role over time.

Long-term patient support therefore requires services that take into account different needs and life stages and can be adapted to changes in the course of treatment. This also involves considering varying levels of health literacy and digital literacy, and ensuring that information and digital services are made accessible and understandable accordingly.

This dynamic is particularly relevant to Healthy Longevity, as health conditions, life circumstances and support needs can change over many years.

 

Understanding Healthcare Provision: Combining Data Sources in a Targeted Manner

Market and healthcare provision data can reveal important patterns. For example, they show which treatments are being used, how prescriptions are evolving, or where changes and interruptions occur.

Such data can therefore provide insights into what is happening within the healthcare system. However, the reasons behind the observed patterns cannot always be identified. An interruption in treatment, for example, may be due to medical, personal or organisational reasons. Conversely, a continuous prescription does not automatically indicate how a treatment is experienced in everyday life.

This is precisely where it is worth looking at different data sources: using health market, prescription, patient and care data from pharmacies and doctors’ practices, Insight Health can carry out in-depth analyses and draw out insights based on its many years of expertise. This enables detailed examination of structural trends, treatment pathways and differences between regions, target groups or specialist groups. Combined with behavioural analyses using real-world data from patients’ everyday lives and direct patient surveys conducted via mediteo, this enables a more nuanced view of healthcare provision, both within healthcare facilities and in people’s everyday lives.

Both perspectives are relevant to issues surrounding Healthy Longevity, as health needs and care situations can change over long periods of time. Depending on the specific issue, they can highlight different aspects of this development:

 

Care provider’s perspective

Patient’s perspective

Which treatments are prescribed?

What information is required?

When do changes or interruptions occur?

What barriers are encountered in everyday life?

What differences exist between regions?

How do the needs of different patient groups differ?

How do treatment pathways develop?

How does the need for support change over time?
 
 

However, analysing different data sources does not automatically result in robust evidence. The insights that can be derived depend largely on the research question, the specific data source, the population under study and the study design. At Insight Health, relevant solutions relating to real-world data are grouped under the term Real-World Insights. What is crucial here is not only the volume of available data, but also its suitability for the specific research question.

Market and healthcare provision data, surveys and digital usage data each provide different insights of healthcare provision and each have their own methodological limitations. For example, users of an app are not automatically representative of the entire patient population, whilst prescription data alone say little about how a treatment is experienced in everyday life. Data quality, potential selection biases, and requirements regarding data protection, consent and purpose limitation should therefore be taken into account from the outset, in a manner appropriate to the respective data source and research question.

 

Four Implications for Pharmaceutical Companies

A Healthy Longevity perspective broadens the traditional view of treatment: in addition to prevention and maintaining good health, the focus with regard to existing conditions is also on minimising the long-term consequences of illness and supporting patients in leading as independent a life as possible.

  1. Considering health and care together in everyday life
    Health is not solely shaped by medical facilities. Working life, family, mobility, health literacy and personal routines all influence how we manage our own health. In the case of existing conditions, these factors also influence how well treatments and disease management can be integrated into everyday life.
  2. Looking beyond the start of treatment
    Patient programs and communication services should not end after the first few weeks following a prescription. Situations may arise later in the course of treatment where guidance or support is needed, for example when treatments are adjusted, side effects occur, or treatment becomes increasingly complex. It is therefore crucial to consider relevant points of contact even beyond the start of treatment.
  3. Taking different needs into account
    What is helpful in everyday life varies from person to person. Life circumstances, health literacy, experience of treatment or individual stressors can influence what information and what form of support are required. Services for patients should take these differences into account, rather than assuming a uniform set of needs.
  4. Selecting data sources based on the research question
    Not every question requires the same data. Care analyses, qualitative research, surveys, patient-reported outcomes and digital usage data offer different perspectives and each has its own strengths and limitations. The starting point should therefore not be which data is available, but rather which specific question needs to be answered.

When it comes to issues relating to healthy longevity, the collaboration between Insight Health and mediteo makes it possible to examine not only the healthcare market and the provision of care, but also the day-to-day health and medication routines of patients.

After all, Healthy Longevity may be measured in years. But it is supported day by day.

 

Sources and further reading